Related Experiment Video

Updated: Jul 19, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Disease progression among HIV-infected children who receive perinatal zidovudine prophylaxis

David R Berk1, Meira S Falkovitz-Halpern, Barbara Sullivan

  • 1Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305-5208, USA.

Journal of Acquired Immune Deficiency Syndromes (1999)
|November 1, 2006
PubMed

Insights

Perinatal zidovudine prophylaxis (PZP) in HIV-infected infants was linked to earlier antiretroviral therapy (ART) initiation and reduced early disease progression. ART remained effective regardless of prior PZP exposure, indicating improved outcomes for infants receiving PZP.

Area of Science:

  • Pediatric Infectious Diseases
  • HIV/AIDS Research
  • Clinical Epidemiology

Background:

  • Mixed results exist on the prognosis of HIV-infected infants exposed to perinatal zidovudine prophylaxis (PZP).
  • Understanding the long-term impact of PZP on disease progression and treatment efficacy is crucial.

Purpose of the Study:

  • To evaluate early HIV disease progression in infants who received PZP.
  • To assess the effectiveness of subsequent antiretroviral therapy (ART) in preventing early disease progression in this cohort.

Main Methods:

  • A population-based cohort of 73 perinatally HIV-infected children with at least 3 years of follow-up was analyzed.
  • Data on PZP administration and subsequent ART initiation were collected.
  • Early HIV disease progression (Category C diagnosis) and age at ART initiation were compared between groups.

Main Results:

  • Children receiving PZP initiated ART earlier (median 2 months) than those not receiving PZP (median 6 months).
  • PZP was associated with decreased progression to Category C diagnosis by age 3 (21% vs. 45%).
  • ART demonstrated similar effectiveness in preventing early HIV progression irrespective of prior PZP exposure.

Conclusions:

  • Perinatally HIV-infected children who received PZP started ART significantly earlier.
  • PZP was associated with reduced HIV disease progression by age 3.
  • ART effectiveness was comparable in children with and without prior PZP exposure.
Abstract

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...